Johnson & Johnson China Kicks Off 2024 with Multiple Awards for Innovation and Social Impact

ShanghaiJanuary 31, 2024PR Newswire -- Recently, Johnson & Johnson won multiple awards for its extensive influence in innovation excellence, employer branding, corporate social responsibility, and public relations communication. These include: being named "Annual Excellence Innovation Enterprise" by Economic Observer for three consecutive years; Song Weiqun, Global Senior Vice President of Johnson & Johnson and Chairman of Johnson & Johnson China, receiving the "Annual Outstanding China Head of a Multinational Corporation" award from Economic Observer; being listed on the 2024 "China Top Employer" list by the Top Employers Institute; winning the "Outstanding Corporate Social Responsibility Award" from Shanghai Daily; and receiving ten awards in the "11th Excellent Public Relations Case Evaluation" by the Shanghai Public Relations Association.

Song Weiqun, Global Senior Vice President of Johnson & Johnson and Chairman of Johnson & Johnson China, stated: "We are greatly honored to start 2024 with this ‘auspicious beginning.’ These awards are important recognitions from all sectors of society for Johnson & Johnson's innovative practices and industry leadership. They also represent high acknowledgment and encouragement for the new chapter in healthcare that Johnson & Johnson has embarked on following the brand renewal. We will continue to be innovation-driven, build an excellent employer brand to attract top talent, contribute to the development of a high-quality healthcare service system in China and the ‘Healthy China’ initiative, and leverage our broad social influence to collaborate with all parties in serving the health needs of the Chinese people."

Adhere to Innovation-Driven Development, Forge a Path of High-Quality Growth

As one of the earliest multinational enterprises to enter China during the initial stages of reform and opening up, innovation has always been the primary driving force behind Johnson & Johnson's development in China. At the 6th Global Business Leaders Forum Dingxin Awards hosted by the Economic Observer, Johnson & Johnson was named "Outstanding Innovative Enterprise of 2023," and Song Weiqun, Global Senior Vice President of Johnson & Johnson and Chairman of Johnson & Johnson China, was honored with the title of "Outstanding Leader of a Multinational Corporation in China for 2023." This marks the third consecutive year that Johnson & Johnson has received these two prestigious awards.

Johnson & Johnson Named "2023 Outstanding Innovative Enterprise of the Year"

Johnson & Johnson Global Senior Vice President and China Chairman, Song Weiqun, Receives "2023 Outstanding Multinational Company China Leader" Honor Again

After nearly 40 years of deep cultivation in China, Johnson & Johnson has consistently served the ever-growing and diverse health needs of 1.4 billion Chinese people with high-quality innovative healthcare products. In addition to accelerating the introduction of global innovations, Johnson & Johnson China continues to advance local R&D innovation, local intelligent manufacturing, and promote the construction of an industry innovation ecosystem by building an open innovation platform. Today, within Johnson & Johnson’s global business landscape, China is not only one of the fastest-growing markets but also a new strategic market for innovation. As the leader of Johnson & Johnson's development in China, Song Weiqun has been driving the company’s innovation-driven, high-quality growth through forward-thinking planning and long-term strategies. He continuously promotes and deepens innovation exchanges and cooperation between Johnson & Johnson and upstream and downstream enterprises in the industry chain, contributing to the development of China’s healthcare industry with his exceptional leadership and influence.

Build an employer brand to attract talent vitality and strength

For years, Johnson & Johnson has continuously empowered its employer brand building through innovative practices, transforming talent into a key growth driver. Recently, the internationally authoritative Top Employers Institute announced the 2024 "Top Employer in China" list, and Johnson & Johnson once again earned the honor and retained its title as a "Top Employer in China" due to its remarkable achievements in corporate culture development and talent cultivation.

Johnson & Johnson Ranks on the 2024 "China Outstanding Employer" List

As a leader in the healthcare industry, Johnson & Johnson actively fosters a diverse, equitable, and inclusive (DE&I) corporate culture, creating a high-quality workplace environment that provides broad development opportunities and a professional platform for diverse talents. It fairly offers opportunities and resources tailored to each employee's different career development needs, enabling every employee to participate in the company’s innovation and growth. At the same time, while focusing on addressing unmet global healthcare needs, Johnson & Johnson places great importance on employees' physical and mental well-being by establishing a comprehensive health benefits system covering occupational health, welfare security, and promoting healthy behaviors. Through various programs, it advances the health management of employees and their families, continuously enhancing employees’ happiness and sense of belonging.

Play a roleExtensive Influence, Practicing Corporate Mission and Responsibility

2023 marks the 80th anniversary of Johnson & Johnson's "Our Credo." Guided by the spirit of the Credo, Johnson & Johnson is committed to promoting human health and building a better society with broad influence. Hosted by the Shanghai Daily,"2023 'Responsibility, Openness, Sharing' Corporate Social Responsibility Awards Selection"In China, Johnson & Johnson China has been honored with the "Outstanding Corporate Social Responsibility Award" for its active commitment to patients, healthcare professionals, talent, the environment, and social responsibility.

Johnson & Johnson Honored with the 2023 "Outstanding Corporate Social Responsibility Award"

As a leading company in the healthcare industry, Johnson & Johnson continuously accelerates the introduction and localization of globally advanced medical innovation solutions, promoting access to quality healthcare resources for a wide range of patients. In addition, it supports the enhancement of healthcare professionals' diagnostic and treatment capabilities through public welfare initiatives, consistently using the power of philanthropy to promote disease awareness and advocate for early diagnosis and treatment. The company actively fulfills its social responsibility in energy conservation and emission reduction, with long-term investments and effective practices in green, low-carbon, and sustainable development across multiple dimensions. Its Medical Technology Industrial Park in Suzhou and pharmaceutical factory in Xi’an have both been awarded the title of "Sustainable Lighthouse Factory" by the World Economic Forum. Furthermore, since 2023, most of Johnson & Johnson’s supply chain bases in China have achieved 100% use of green electricity. Across the entire value chain, Johnson & Johnson actively collaborates with supplier partners, providing services with innovative insights while driving upstream partners to fulfill their green commitments and corporate social responsibilities.

Leading Health Communication,Supporting the "Healthy China" Initiative

In the past few years, while leveraging its industry influence, Johnson & Johnson has also actively collaborated with various sectors of society to innovatively create public relations campaigns with significant social impact. At the "11th Excellent Public Relations Case Awards" hosted by the Shanghai Public Relations Association, Johnson & Johnson won ten awards for its innovative and diverse public relations practices and high-quality communication outcomes. These included two gold awards (the "A Lifetime with Johnson & Johnson" corporate brand communication project and the "Pink Bloom" breast cancer post-surgery breast reconstruction public welfare health campaign supported by Johnson & Johnson Medical), six silver awards ("Exerting Social Influence, Practicing Corporate Social Responsibility, and Building a Healthy China Together" project, Johnson & Johnson China's contribution to the "Common Prosperity" vision project, "Johnson & Johnson China Enhances Corporate Culture Construction, Promoting Business and Talent Development Together" project, the "Starlight Action" cerebrovascular health education public welfare campaign supported by Johnson & Johnson Medical, "The Light of Small Holes" 30th anniversary of the development of laparoscopic surgery in China, and the "New Journey in Life" bariatric surgery public welfare health campaign, "Healthy 'Together' in Motion" sports medicine health education project), an Outstanding Planning Creativity Award ("Loving Eyes with Heart, Connecting Visions" Guinness World Record challenge on World Sight Day), and an Outstanding Brand Communication Award ("Guarding with Love, Moving Forward for EYE" national eye care day online public welfare communication project supported by Johnson & Johnson Vision).

Johnson & Johnson Wins Ten Awards in the "11th Outstanding Public Relations Case Selection"

Innovation-Driven Development, Forging Ahead to Write a New Chapter. Standing at a new historical starting point, the new Johnson & Johnson focuses on the expertise of its two major business fields—medical technology and innovative pharmaceuticals—and leverages its unique comprehensive strength to continue collaborating with all parties to promote the high-quality development of China's healthcare industry and public health sector, bringing profound impacts to the cause of human health.